MaryannJKwaMD

PubMed

• Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches.
  Elad Mashiach, Juan Diego Alzate, Fernando De Nigris Vasconcellos, Sylvia Adams, Brandon Santhumayor, Ying Meng, Zane Schnurman, Bernadine R Donahue, Kenneth Bernstein...> ;Journal of Neuro-Oncology. 2024 Apr 17
• Long-term Survival From Breast Cancer Brain Metastases in the Era of Modern Systemic Therapies.
  Mashiach, E., Alzate, J., De Nigris Vasconcellos, F., Bernstein, K., Donahue, B., Schnurman, Z., Gurewitz, J., Rotman, L., Adams, S., Meyers, M., Oratz, R., Novik, Y.,...> ;Neurosurgery. 2024 Jan 1
• 2 citations
  Radiation in Early-Stage Breast Cancer: Moving beyond an All or Nothing Approach.
  Juhi M Purswani, Camille Hardy-Abeloos, Carmen A Perez, Maryann J Kwa, Manjeet Chadha, Naamit K Gerber> ;Current Oncology. 2022 Dec 23
• Outcomes of Breast Cancer Patients Treated with Chemotherapy, Biologic Therapy, Endocrine Therapy, or Active Surveillance During the COVID-19 Pandemic.
  Douglas K Marks, Nibash Budhathoki, John Kucharczyk, Faisal Fa'ak, Nina D'Abreo, Maryann Kwa, Magdalena Plasilova, Shubhada Dhage, Phyu Phyu Soe, Daniel Becker, Alexan...> ;The Oncologist. 2022 Mar 4
• 37 citations
  Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytes
  Nancy Tray, Jessica Taff, Baljit Singh, James Suh, Nhu Ngo, Maryann Kwa, Andrea B. Troxel, Young Kwang Chae, Razelle Kurzrock, Sandip Pravin Patel, Elad Sharon, Carste...> ;Breast. 2019 Apr 1
• 124 citations
  Checkpoint inhibitors in triple‐negative breast cancer (TNBC): Where to go from here
  Maryann J. Kwa, Sylvia Adams> ;Cancer. 2018 May 15
• 14 citations
  Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer.
  Maryann Kwa, Xiaochun Li, Yelena Novik, Ruth Oratz, Komal Jhaveri, Jennifer Wu, Ping Gu, M Meyers, Franco M. Muggia, James L. Speyer, Alyssa Iwano, Maryam Bonakdar, Li...> ;Breast Cancer Research and Treatment. 2018 Feb 1
• 164 citations
  Clinical utility of gene-expression signatures in early stage breast cancer.
  Maryann Kwa, Andreas Makris, Francisco J. Esteva> ;Nature Reviews. Clinical Oncology. 2017 May 31
• 281 citations
  The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer.
  Maryann Kwa, Claudia S. Plottel, Martin J. Blaser, Sylvia Adams> ;Journal of the National Cancer Institute. 2016 Aug 1
• 12 citations
  Giant acquired reactive perforating collagenosis in a patient with diabetes mellitus and metastatic breast carcinoma
  Randie H. Kim, Maryann Kwa, Sylvia Adams, Shane A Meehan, Jennifer A. Stein> ;JAAD Case Reports. 2016 Jan 1
• 24 citations
  Ovarian cancer in BRCA mutation carriers: improved outcome after intraperitoneal (IP) cisplatin.
  Maryann Kwa, Susan Edwards, Andrea Downey, Elsa Reich, Robert C. Wallach, John P. Curtin, Franco M. Muggia> ;Annals of Surgical Oncology. 2014 May 1
• 9 citations
  Ovarian Cancer: A Brief Historical Overview of Intraperitoneal Trials
  Maryann Kwa, Franco M. Muggia> ;Annals of Surgical Oncology. 2014 May 1
• 10 citations
  Pegylated liposomal doxorubicin and renal thrombotic microangiopathy: an under-recognized complication of prolonged treatment for ovarian cancer
  Linda Shavit, Meyer Lifschitz, Alberto Gabizon, Maryann Kwa, Franco M. Muggia, Itzchak Slotki> ;Kidney International. 2014 Jan 1
• 16 citations
  Is Renal Thrombotic Angiopathy an Emerging Problem in the Treatment of Ovarian Cancer Recurrences
  Maryann Kwa, Robert Baumgartner, Linda Shavit, Irina Barash, Jeffrey Michael, Igor Puzanov, Juri Kopolovic, Ora Rosengarten, Stephanie V. Blank, John P. Curtin, Albert...> ;The Oncologist. 2012 Dec 1
• Join now to see all

Lectures

• Phase II trial of nivolumab with chemotherapy as neoadjuvant treatment in inflammatory breast cancer. 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019